Harpoon Therapeutics, Inc. [·] Shares Common Stock ($0.0001 par value per share) Underwriting AgreementHarpoon Therapeutics, Inc. • January 29th, 2019 • Biological products, (no disgnostic substances) • New York
ASSET TRANSFER AGREEMENT BETWEEN MAVERICK THERAPEUTICS, INC. AND HARPOON THERAPEUTICS, INC. Dated as of December 30, 2016 CONFIDENTIALAsset Transfer Agreement • January 29th, 2019 • Harpoon Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
* = This schedule or exhibit has been omitted in accordance with Item 601(b)(2) of Regulation S-K. A copy of the omitted schedule and/or exhibit will be furnished to the Securities and Exchange Commission on request.
ContractHarpoon Therapeutics, Inc. • January 29th, 2019 • Biological products, (no disgnostic substances) • New York
[ ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.
